POLOCAINE (MEPIVACAINE HCl) NDC 51662-1534

NDC codes

FDA NDC Directory

Product NDC (as listed)51662-1534Labeler and product segments. Claims need a package NDC.

Product NDC at billing width51662-1534Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package	Copy
51662-1534-3	51662153403	25 POUCH in 1 BOX (51662-1534-3) / 1 VIAL, MULTI-DOSE in 1 POUCH (51662-1534-2) / 50 mL in 1 VIAL, MULTI-DOSEMarketed from May 11, 2021

How the 11-digit form is made: The package segment has 1 digit, so one leading zero is added to it (5-4-1 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): POLOCAINE (MEPIVACAINE HCl)
Generic name (nonproprietary): polocaine (mepivacaine hcl)
Active ingredients: Mepivacaine hydrochloride — 10 mg/mL
Dosage form: Injection, Solution
Route: Infiltration
Labeler: HF Acquisition Co LLC, DBA HealthFirst
Product type: Prescription drug
Marketing category: ANDA — Abbreviated New Drug Application (generic)Application ANDA 089407
Marketing start: May 11, 2021
Listing expires: Dec 31, 2026
Other FDA classes: Amides (Chemical structure)Local Anesthesia (Physiologic effect)
Identifiers: Product ID 51662-1534_1034b916-15a5-44be-e063-6394a90a2c0bSPL ID 1034b916-15a5-44be-e063-6394a90a2c0bSPL set ID c21a4c3a-82c0-0bfb-e053-2995a90a2b65RxCUI 1012722UNII 4VFX2L7EM5UPC 0363323283018
Pharmacologic class: Amide Local Anesthetic

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No drug-specific HCPCS code in Med-Code's directory for this product. The directory is curated and not complete — check the current CMS HCPCS file before billing.

NDC on a medical claim

N451662153403 followed by a unit qualifier and the quantity

Package 51662-1534-03. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Jan 30, 2024.

Indications (excerpt from the label)

INDICATIONS & USAGE POLOCAINE (Mepivacaine HCl Injection, USP), is indicated for production of local or regional analgesia and anesthesia by local infiltration, peripheral nerve block techniques, and central neural techniques including epidural and caudal blocks. The routes of administration and indicated concentrations for mepivacaine are: See DOSAGE AND ADMINISTRATION for additional information. Standard textbooks should be consulted to determine the accepted procedures and techniques for the administration of mepivacaine. INDICATIONS

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

Other NDCs under ANDA 089407

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under ANDA 089407
Product	Strength	Form · route	Labeler	Product NDC
Polocainemepivacaine hydrochloride	Mepivacaine hydrochloride 10 mg/mL	Injection, SolutionInfiltration	Fresenius Kabi USA, LLC	63323-283